Neuraminidase and cap-dependent endonuclease — Drug Target

All drugs that target Neuraminidase and cap-dependent endonuclease — marketed and clinical-stage. Includes 1 drug classes acting on this target.

Drug classes

Neuraminidase inhibitor and cap-dependent endonuclease inhibitor

Phase 3 pipeline (1)

• Ten-days oseltamivir + baloxavir marboxil · UMC Utrecht · Neuraminidase inhibitor and cap-dependent endonuclease inhibitor · Infectious Diseases
  Oseltamivir is a neuraminidase inhibitor that blocks the release of influenza virus from infected cells, while baloxavir marboxil is a cap-dependent endonuclease inhibitor that blocks viral replication.